Cancer continues to be a significant health challenge across Africa, with limited treatment options and diagnostic tools. But behind every statistic is a personal story, like that of countless individuals battling life-threatening diseases without adequate support.
AIMS Pharma is dedicated to transforming healthcare access by delivering cutting-edge, affordable treatments in cancer and neurodegenerative diseases. Through sustainable practices, innovative distribution, and strategic partnerships, we bridge the gap between global pharmaceutical innovations and African communities.
Our commitment ensures that patients receive timely, life-saving treatments, empowering healthcare professionals and fostering long-term growth across the continent.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Saint-Maur-Des-Fosses, Fr
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.aims-pharma.com
- Keywords
- Pharmaceutical Distribution, Oncology and Cancer Care, Healthcare Access, Innovative Treatment Solutions, Medical Education and Training, Sustainable Healthcare Practices, Healthcare Partnerships and Collaboration, Africa Healthcare, Cancer therapy, Precision Medicine, Africa growth.
- HQ
- Saint-Maur-Des-Fosses
Aims Pharma Questions
Aims Pharma's website is http://www.aims-pharma.com
Aims Pharma's LinkedIn profile is https://fr.linkedin.com/company/aims-pharma
Aims Pharma has
8 employees.
View email and phone details for 8
employees at Aims Pharma.
Aims Pharma's industry is
Pharmaceutical Manufacturing
Aims Pharma's top competitors are
Hikma Pharmaceuticals,
Galderma,
Teva Pharmaceuticals,
Mc Pharma,
Adwya,
Prontohq,
Al Adrak Trading And Contracting Co Llc,
Mayoly,
Sanofi,
Mc Pharma.
Aims Pharma's categories are Pharmaceutical Manufacturing
Aims Pharma's founding year is 2024
